Daijun zhou

Dr. Daijun zhou


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2022 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JHJie Hao
Jie Hao
MSMengyi Sun
Mengyi Sun
DLDong Li
Dong Li
TZtao zhang
tao zhang
JLJianjun Li
Jianjun Li
DZDaijun zhou
Daijun zhou
Radiation-induced skin injury (RISI) is a common complication of radiotherapy. Interferon-alpha inducible protein 6 (IFI6) significantly reduces the radiation sensitivity of HaCaT cells. Sodium alginate (SA) has substantial moisturizing properties. Graphene oxide (GO) is a suitable substrate with physical antibacterial properties. Therefore, we designed materials to modify IFI6 using the biogule of polydopamine (PDA) connected to GO/SA. The structure, size, morphology, and elemental compositions of IFI6-PDA@GO/SA were analyzed. Cytological studies suggested that IFI6-PDA@GO/SA is non-toxic to HaCaT cells, with antibacterial properties. It promotes migration and vascularization and inhibits apoptosis. These cells express IFI6 after irradiation. The mouse model suggested that IFI6-PDA@GO/SA promotes wound healing and reduces reactive oxygen species expression. IFI6-PDA@GO/SA accelerates RISI healing, possibly by initiating the SSBP1/HSF1 signaling pathway. In addition, IFI6-PDA@GO/SA improves the immune microenvironment. This study constitutes the first use of IFI6 as a RISI wound-healing material.

16 October 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
DHDan He
Dan He
ZLZhiHui Li
ZhiHui Li
MWMin Wang
Min Wang
DKDejun Kong
Dejun Kong
WGWenyan Guo
Wenyan Guo
DZDaijun zhou
Daijun zhou
In patients with abdominal or pelvic tumors, radiotherapy can result in radiation-induced intestinal injury (RIII), a potentially severe complication for which there are few effective therapeutic options. Sitagliptin (SI) is an oral hypoglycemic drug that exhibits antiapoptotic, antioxidant, and anti-inflammatory activity, but how it influences RIII-associated outcomes has yet to be established. In this study, a pH-responsive metal-organic framework-based nanoparticle platform was developed for the delivery of SI (SI@ZIF-8@MS NP). These NPs incorporated mPEG-b-PLLA (MS) as an agent capable of resisting the effects of gastric acid, and are capable of releasing Zn2+ ions. MS was able to effectively shield these SI@ZIF-8 NPs from rapid degradation when exposed to an acidic environment, enabling the subsequent release of SI and Zn2+ within the intestinal fluid. Notably, SI@ZIF-8@MS treatment was able to mitigate radiation-induced intestinal dysbiosis in these mice. restored radiation-induced changes in bacterial composition. In summary, these data demonstrate the ability of SI@ZIF-8@MS to protect against WAI-induced intestinal damage in mice, suggesting that these NPs represent a multimodal targeted therapy that can effectively be used in the prevention or treatment of RIII.

4 July 2024 in Microbial Pathogenesis
Verified
Journal Article
Closed access
JDJieyin Deng
Jieyin Deng
YHYe Huang
Ye Huang
KYKe Yu
Ke Yu
HLHong Luo
Hong Luo
DZDaijun zhou
Daijun zhou
DLdong li
dong li

29 July 2025 in Materials Today Bio
Verified
Journal Article
Open access
ZLZhiHui Li
ZhiHui Li
DHDan He
Dan He
YZYe Zhang
Ye Zhang
ZSZhou Shi
Zhou Shi
QTQuanjin Tang
Quanjin Tang
DZDaijun zhou
Daijun zhou
Radiation-induced oral mucositis (RIOM) is the most common oral complication faced by patients with head and neck cancer undergoing radiotherapy or chemotherapy, significantly diminishing their quality of life. While previous studies have investigated single K12 probiotics for RIOM, they often lacked stability, free radical scavenging activity, and precise oral targeting. To overcome these challenges, we developed K12@Lip@GSH, an innovative oral probiotic that encapsulates K12 within liposomes to enhance stability and scavenging efficacy, while utilizing a glutathione (GSH) transporter-mediated targeting mechanism that exploits the favorable the overexpression of GSH transporters in RIOM. Evaluations conducted in RIOM mouse models subjects demonstrated favorable outcomes, including a reduction in ulcer size, increased epithelial cellularity and mucosal thickness, enhanced epithelial proliferation, and decreased apoptosis. Genomic analysis further indicated improvements in mRNA pathways associated with the recovery from RIOM. Additionally, K12@Lip@GSH was shown to restore the balance of oral microbiota and reduce the abundance of oral anaerobes in RIOM mice. Subsequently, the safety and efficacy of K12@Lip@GSH were confirmed through further single-arm, single-center prospective clinical trials. The clinical trial data demonstrated a manageable safety profile in the cohort of 22 enrolled patients. Treatment-related adverse events (TRAEs) were infrequent, occurring in only 4.5 % of participants, with reported symptoms including flatulence and dyspepsia. Although 59.1 % of patients experienced oral mucositis (OM), the incidence of severe OM (grade 4) was 0.0 %, and no interruptions in radiotherapy treatment occurred due to OM. Overall, K12@Lip@GSH shows promise as an adjuvant strategy for improving radiation-induced oral mucositis (RIOM) in cancer patients undergoing radiotherapy.

10 January 2019 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
DZDaijun zhou
Daijun zhou
TYTao Yang
Tao Yang
GLGaoxing Luo
Gaoxing Luo
This study aimed to prepare an anti-infective Eco-friendly dressing of chitin-lysozyme, which should have antibacterial activity in vitro and promote wound healing in vivo. The chitin-lysozyme was prepared using chitin (group Control) and dopamine gule (group A) methods respectively, at 2mg/ml, 4mg/ml, and 8mg /ml (Namely group B, C and D). Finally, the chitin-lysozyme was observed as lysozyme spherical particles and bedding dopamine colloid. FTIR showed that the lysozyme had been adhered and the contact angle test showed that the material was hydrophilic. In vitro antibacterial effect was significant and the role on E. coli was significantly weaker than that on S. aureus. The cytotoxicity of the chitin-lysozyme dressing was not found. On day 7, the healing rates were 35.2%, 37.9%, 56.4%, 71.9% and 75.1% in Group Control, A, B, C and D, respectively. The wound healing rate was higher in the C and D groups than these in the other three groups (P <0.05).

1 September 2022 in Materials Research Express
Verified
Journal Article
Open access
PDF file
DZDaijun zhou
Daijun zhou
PTPeng Tian
Peng Tian
DLDong Li
Dong Li
JLJianjun Li
Jianjun Li
TZtao zhang
tao zhang
Herein, a series of environmentally friendly dressings were specially fabricated from graphene oxide (GO) membrane (a high quality substrate with antibacterial function) and Daptomycin (antibacterial function)/Epidermal growth factor (EGF, wound healing function) for the purpose of antibacterial applications. A performance comparison was designed by employing four dressing samples, including the neat GO membrane (Group A), GO membrane-Daptomycin (Group B), GO membrane-EGF (Group C), and GO membrane-Daptomycin/EGF (Group D). The results analyzed using Fourier transform infrared spectroscopy suggested that Daptomycin and EGF might be adhered to the GO membrane. The contact angle test showed that the hydrophilicity of material gradually increased from Group A to Group D. Groups B and D displayed similar in vitro antibacterial activities, better than those of Groups A and C (their antibacterial performances were similar to each other); all the four experimental groups outperformed the control group (P > 0.05). On the other hand, Groups C and D could promote the proliferation effectively within 1–7 days (P < 0.05), and they also showed similar activities in the cell migration, which were higher than those of Groups A and B (close to each other); all the experimental groups outdid the control group (P < 0.05). Moreover, by monitoring the expression levels of PCNA and CD31 , samples from Group D could promote both angiogenesis and cell reproduction when covering the skin defects (P < 0.05). At the seventh days after the injury, the control and experimental groups of A, B, C, and D displayed healing rates of 40.6%, 53.0%, 66.8%, 60.1%, and 68.3%, respectively. Based on a successful fabrication of GO membrane-Daptomycin/EGF dressings, antibacterial effects as well as growth-promoting performance were well realized by samples in Group D. This is benifitial for the wound healing to a great extent.